The Effect of Semi Fowler 30' Right Lateral on Cardiac Output in Acute Heart Failure

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-09-01

Study Completion Date

2023-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Heart failure is a special clinical syndrome such as difficulty breathing, fatigue, and swollen legs characterized by increased JVP, crackle lung sounds, and peripheral edema caused by heart disorders both structural and/or functional, resulting in decreased cardiac output and increased intracardiac pressure at rest and activity. Body positioning has been shown to affect stroke volume and parasympathetic modulating activity. The right lateral 30" semifowler position is a very safe position in heart failure patients admitted to the ICU. Although body positioning can affect stroke volume, and parasympathetic modulation, it is not yet clear what effect it has on cardiac output

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Management of Depression and Anxiety in HF

NCT04636944

Heart Failure Depression Anxiety

COMPLETED

Change in Stroke Volume Index After Diuresis for Patients With Decompensated Heart Failure

NCT05240651

Acute Decompensated Heart Failure

RECRUITING

Fluid Restriction in Patients With Heart Failure

NCT04611594

Heart Failure, Systolic Heart Failure; With Decompensation Pulmonary Congestion

UNKNOWN NA

Comparison of Outcomes and Access to Care for Heart Failure Trial

NCT02674438

Heart Failure

COMPLETED PHASE3

Mechanisms of Pulmonary Vascular Dysfunction in Heart Failure

NCT06331208

Heart Failure Pulmonary Hypertension Pulmonary Vascular Resistance Abnormality

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cardiac Output, High Heart Failure Pulmonary Edema With Heart Failure Dyspnea; Cardiac Arrythmia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Semi-fowler 30" Right Lateral

Group Type EXPERIMENTAL

Semifowler 30' Right Lateral Body Position

Intervention Type BEHAVIORAL

Semifowler 30' Right Lateral Body Position Is a regulation of body position by placing the patient's body in a semi-fowler and lateral resting position of 30 degrees

Conventional care

Group Type ACTIVE_COMPARATOR

Semifowler 30' Right Lateral Body Position

Intervention Type BEHAVIORAL

Semifowler 30' Right Lateral Body Position Is a regulation of body position by placing the patient's body in a semi-fowler and lateral resting position of 30 degrees

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Semifowler 30' Right Lateral Body Position

Semifowler 30' Right Lateral Body Position Is a regulation of body position by placing the patient's body in a semi-fowler and lateral resting position of 30 degrees

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* The patient was diagnosed with acute decompensated heart failure,
* fully conscious,
* not intubated,
* \>18 years old,
* had no mobility problems,
* palpable radial artery pulsation,
* was not under the influence of anti-hypotensive drugs,
* willing to be a respondent,
* LVEF \<50%.

Exclusion Criteria

* Pulmonary edema,
* severe valve disease comorbidities,
* receiving high doses of anti-hypotensive treatment,
* heart failure readmission in the last 3 months,
* finger edema,
* use of mechanical circulatory support,
* irregular rhythms,
* artificial pacemaker attached,
* obesity
* peripheral perfusion disorders
* cardiogenic shock

Minimum Eligible Age

18 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No